Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial.

Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. Mayo Clin Proc. 2003 Jun; 78(6):687-95.

View in: PubMed

subject areas

Administration, Oral
Aged
Benzhydryl Compounds
Constipation
Cresols
Delayed-Action Preparations
Diarrhea
Double-Blind Method
Female
Headache
Humans
Mandelic Acids
Middle Aged
Muscarinic Antagonists
Phenylpropanolamine
Prospective Studies
Salivation
Tartrates
Tolterodine Tartrate
Treatment Outcome
Urinary Incontinence
Urinary Tract Infections
Urination

authors with profiles

Peter Sand